Lupus Foundation of America7d
UPDATE: Phase 1 Trial Begins for Investigational Therapy, CB-010, for Lupus Nephritis Treatment
The Phase 1 GALLOP study evaluating the investigational therapy, CB-010, for treatment of lupus nephritis has launched.
Lupus Foundation of America9d
New Study Finds Systemic Lupus Erythematosus is a Risk Factor for Developing Multiple Cutaneous Lupus Erythematosus Subtypes
Lupus affects different people in different ways, and skin problems like rashes or sores re common. In a new study, people ...